Last reviewed · How we verify
0.2% isoflurane
At a glance
| Generic name | 0.2% isoflurane |
|---|---|
| Sponsor | University of Chicago |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Total Intravenous and Balanced Anesthesia in Diabetic Patients Undergoing Video-Assisted Thoracoscopy (PHASE4)
- GA + ESP vs. SA + ESP in Lumbar Decompression Surgeries (PHASE3)
- Exploring the Impact of Genetic Variations on The Clinical Efficacy of Nalbuphine in Postoperative Pain Management (PHASE2, PHASE3)
- Opioid Free Anesthesia in Shoulder Arthroscope (PHASE1)
- Evaluating Perioperative Outcomes: Dexmedetomidine vs Lignocaine in Laparoscopic Chlolecystectomy (PHASE2, PHASE3)
- Effect of Ketalar or Dexmedetomidine on Increased Sensitivity to Pain Following Treatment With Remifentanil (NA)
- Interaction of Volatile Anesthetics With Magnesium (PHASE4)
- Comparing Quality of Recovery Between Desflurane & Isoflurane in Eye Surgery Patients at Dr George Mukhari Acad Hospital (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |